Abstract
Patients Experiencing Early Virologic Failure on a Protease Inhibitor- or Nonnucleoside Reverse Transcriptase Inhibitor-Based Initial Regimen Containing a Thymidine Analogue and Lamivudine Can Be Successfully Treated With a Quadruple-Nucleoside Regimen
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAIDS Journal of Acquired Immune Deficiency Syndromes
Paper Title
Journal
Date
